Analyst consensus rating
Turn Therapeutics Analyst Rating: none
Direct answer
Turn Therapeutics's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $25.00.
Forecast evidence checked November 9, 2026.
Get free Turn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.76
- Average price target
- $25.00
- High price target
- $26.00
- Low price target
- $24.00
- Low target gap
- +145.9%
- Target upside
- +156.1%
- High target gap
- +166.4%
- Target range width
- 20.5%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- November 9, 2026
- Valid through
- November 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Turn Therapeutics?
Turn Therapeutics has a verified none consensus. The same dataset has an average price target of $25.00.
How far are Turn Therapeutics's low and high targets from the recorded price?
The low target implies +145.9%, while the high target implies +166.4%.
How many analysts are included in Turn Therapeutics's consensus?
The verified consensus includes 2 analysts.
How is Turn Therapeutics's target upside or downside calculated?
The average target of $25.00 is divided by the recorded price of $9.76, then one is subtracted to produce +156.1%. This does not guarantee a future return.
When was Turn Therapeutics's analyst forecast verified?
The data was verified on 2026-11-09. The dataset is valid through 2026-11-16.